EXAS vs VSTM · rev $2.76B vs rev $58.7M
EXACT Sciences Corporation (EXAS) versus Verastem Inc (VSTM) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Verastem Inc (VSTM) is a biotechnology company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported VSTM revenue for 2026-06-30 was $58.7M. Net income was -$71.3M. VSTM currently screens at market cap $264.3M.
EXAS currently screens at market cap $20.03B. VSTM currently screens at market cap $264.3M.
Not investment advice. Open the EXAS and VSTM stock pages for the full models.
Not investment advice.